跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Skyrizi 150 mg - SFDA Drug Approval Details
Approvals
/
SFDA
/
Skyrizi 150 mg
Authorized
BIOLOGICAL
Skyrizi 150 mg
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
a2f60cfd6c6243c1
Company
Unknown
Type
Biological
Approval Details
Approval Id
a2f60cfd6c6243c1
Drug Approval Sfda Name
Skyrizi 150 mg
Trade Name
Skyrizi 150 mg
Generic Name
RISANKIZUMAB
Register Number
1410211182
Register Year
2021
Drug Type
Biological
Route Of Administration
Subcutaneous use
Package Type
Pre-filled pen
Package Size
1
Size
1
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
7000001107-150-100000073863
Price
12733.3
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
a2f60cfd6c6243c1
Type
Biological
Back to SFDA Approvals